We are live on ! Find out more
LC

Lindbrook Capital Portfolio holdings

AUM $1.08B
1-Year Est. Return 10.14%
This Fund
S&P 500
This Quarter Est. Return
+7.65%
1 Year Est. Return
+10.14%
3 Year Est. Return
+35.77%
5 Year Est. Return
+141.26%
10 Year Est. Return
–
AUM
$939M
AUM Growth
+$86.2M
Cap. Flow
+$29.6M
Cap. Flow %
3.15%
Top 10 Hldgs %
46.18%
Holding
2,925
New
150
Increased
988
Reduced
857
Closed
215

Top Buys

Rank Stock Value
1
VXUS icon
Vanguard Total International Stock ETF
VXUS
+$5.37M
2
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$3.7M
3
VTI icon
Vanguard Morningstar Total Stock Market ETF
VTI
+$2.54M
4
QQQ icon
Invesco QQQ Trust
QQQ
+$2.12M
5
NVDA icon
NVIDIA
NVDA
+$1.88M

Top Sells

Rank Stock Value
1
VRTX icon
Vertex Pharmaceuticals
VRTX
+$6.88M
2
XLP icon
State Street Consumer Staples Select Sector SPDR ETF
XLP
+$4.62M
3
OCSL icon
Oaktree Specialty Lending
OCSL
+$825K
4
MGI
MoneyGram International, Inc. New
MGI
+$627K
5
ISEE
IVERIC bio, Inc. Common Stock
ISEE
+$562K

Sector Composition

Rank Sector Weight
1 Financials 16.18%
2 Technology 15.3%
3 Healthcare 6.27%
4 Consumer Discretionary 3.61%
5 Industrials 3.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BIPC icon
2601
Brookfield Infrastructure
BIPC
$4.85B
$319 ﹤0.01%
7
– –
EWCZ
2602
DELISTED
European Wax Center
EWCZ
$317 ﹤0.01%
+17
New +$304
ZUMZ icon
2603
Zumiez
ZUMZ
$339M
$317 ﹤0.01%
+19
New +$318
VCIT icon
2604
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
$66.3B
$316 ﹤0.01%
4
– –
PRM icon
2605
Perimeter Solutions
PRM
$5.77B
$314 ﹤0.01%
51
+24
+89% +$161
STRO icon
2606
Sutro Biopharma
STRO
$421M
$312 ﹤0.01%
+7
New +$348
NSL
2607
DELISTED
NUVEEN SENIOR INCM FD
NSL
$311 ﹤0.01%
68
– –
SCS
2608
DELISTED
Steelcase
SCS
$308 ﹤0.01%
40
-148
-79% -$1.12K
SMBC icon
2609
Southern Missouri Bancorp
SMBC
$850M
$308 ﹤0.01%
8
-2
-20% -$74
ESMT
2610
DELISTED
EngageSmart, Inc.
ESMT
$305 ﹤0.01%
16
-85
-84% -$1.51K
LEVI icon
2611
Levi Strauss
LEVI
$9.39B
$303 ﹤0.01%
+21
New +$303
SRG
2612
Seritage Growth Properties
SRG
$136M
$303 ﹤0.01%
+34
New +$272
ZYME icon
2613
Zymeworks
ZYME
$1.67B
$302 ﹤0.01%
+35
New +$313
RMR icon
2614
The RMR Group
RMR
$332M
$301 ﹤0.01%
13
-66
-84% -$1.54K
XMTR icon
2615
Xometry
XMTR
$5.34B
$297 ﹤0.01%
14
-73
-84% -$1.28K
FLGT icon
2616
Fulgent Genetics
FLGT
$527M
$296 ﹤0.01%
8
-29
-78% -$1.01K
LXU icon
2617
LSB Industries
LXU
$693M
$296 ﹤0.01%
+30
New +$287
PR
2618
Permian Resources
PR
$16.9B
$296 ﹤0.01%
+27
New +$276
SOVO
2619
DELISTED
Sovos Brands, Inc. Common Stock
SOVO
$293 ﹤0.01%
+15
New +$271
COHU icon
2620
Cohu
COHU
$2.5B
$291 ﹤0.01%
+7
New +$258
KALU icon
2621
Kaiser Aluminum
KALU
$3.02B
$287 ﹤0.01%
4
-46
-92% -$3.04K
TNET icon
2622
TriNet
TNET
$3.14B
$285 ﹤0.01%
+3
New +$273
ZIP icon
2623
ZipRecruiter
ZIP
$423M
$284 ﹤0.01%
16
– –
AAP icon
2624
Advance Auto Parts
AAP
$3.49B
$281 ﹤0.01%
4
-7
-64% -$720
TROX icon
2625
Tronox
TROX
$1.04B
$280 ﹤0.01%
22
-148
-87% -$1.86K
103 104
105
106 107

Similar funds

SBIA
Sheaff Brock Investment Advisors Indianapolis, Indiana $1.09B AUM 14.4% 1-Year Est. Return
CHP
Cable Hill Partners Portland, Oregon $1.02B AUM 8.59% 1-Year Est. Return
MW
Marcum Wealth Cleveland, Ohio $1.16B AUM 6.7% 1-Year Est. Return
TAM
Taurus Asset Management New York $986M AUM 5.04% 1-Year Est. Return
SIA
Schechter Investment Advisors Birmingham, Michigan $1.21B AUM 8.72% 1-Year Est. Return
CIG
CCM Investment Group Northfield, Minnesota $946M AUM
CCM
CAAS Capital Management New York $934M AUM 1.45% 1-Year Est. Return
WCF
West Coast Financial Santa Barbara, California $876M AUM 5.74% 1-Year Est. Return

Lindbrook Capital's Q2 2023 Portfolio in Review

As of Q2 2023, Lindbrook Capital held 2,925 positions worth $939M, up 10% from $853M the previous quarter. Its ten largest holdings account for 46% of the portfolio.

Lindbrook Capital deployed $29.6M of net new capital in Q2 2023, opening 150 new positions and adding to 988 existing holdings. Its largest new stake was UPAR Ultra Risk Parity ETF: 21,000 shares worth $291K.

By sector, the portfolio is most concentrated in Financials at 16% of assets, down from 17% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was Vertex Pharmaceuticals, an estimated $6.88M trimmed.

  • Lindbrook Capital's largest Q2 2023 buy was UPAR Ultra Risk Parity ETF: 21,000 shares worth $291K.
  • Lindbrook Capital added most to Vanguard Total International Stock ETF in Q2 2023, an estimated $5.37M increase.
  • Lindbrook Capital's biggest Q2 2023 reduction was Vertex Pharmaceuticals, cutting an estimated $6.88M.
  • Lindbrook Capital fully exited MoneyGram International, Inc. New in Q2 2023, selling an estimated $627K.
  • Lindbrook Capital's ten largest holdings make up 46% of its $939M portfolio in Q2 2023.
  • Lindbrook Capital opened 150 new positions and closed 215 in Q2 2023.
  • Lindbrook Capital's portfolio value rose 10% quarter-over-quarter to $939M.

Based on Lindbrook Capital's 13F filing for Q2 2023, filed 31 Jul 2023.